deltatrials
Unknown PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT03399253

Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor

A Prospective,Multicentral,Open-label,Randomized,Controlled,Phase III Clinical Trial of Chemotherapy Alone Versus D2 Gastrectomy and Metastasectomy Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor

Sponsor: Sun Yat-sen University

Conditions Gastric Cancer
Updated 5 times since 2018 Last updated: Jan 8, 2018 Started: Dec 10, 2017 Primary completion: Nov 1, 2022 Completion: Dec 1, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Gastric Cancer, this trial is ongoing. The trial is conducted by Sun Yat-sen University and has accumulated 5 data snapshots since 2017. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Feb 2018 – ~Jan 2021 · 35 months · monthly snapshotRecruiting~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – ~Jan 2026 · 16 months · monthly snapshotRecruiting~Jan 2026 – present · 6 months · monthly snapshotUnknown

Change History

5 versions recorded
  1. Jan 2026 — Present [monthly]

    Unknown PHASE2/PHASE3

    Status: RecruitingUnknown

  2. Sep 2024 — Jan 2026 [monthly]

    Recruiting PHASE2/PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE2/PHASE3

    Phase: PHASE2_PHASE3PHASE2/PHASE3

  4. Jan 2021 — Jul 2024 [monthly]

    Recruiting PHASE2_PHASE3

  5. Feb 2018 — Jan 2021 [monthly]

    Recruiting PHASE2_PHASE3

    First recorded

Dec 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Sun Yat-sen University
Data source: Sun Yat-sen University

For direct contact, visit the study record on ClinicalTrials.gov .